spacer
home > > autumn 2008 > electric avenue
PUBLICATIONS


Electric Avenue

THE BENEFITS OF ELECTRONIC DATA CAPTURE

The promise of information technology is being realised by businesses around the world. This is evidenced is in the way computing power allows tasks, and even entire processes, to be completed whilst providing the additional benefits of improved methodologies, higher speeds and lower costs. Now, stakeholders of electronic data capture (EDC) are looking to achieve similar benefits in their clinical trial processes earlier on, prior to deploying a finished solution. Some believe the answer lies in a more effective way of implementing EDC. They contend that the days of expensive technology transfer, long implementation times and resource-intensive processes are coming to an end.

As the pharmaceutical industry moves higher up the learning and experience curves for EDC, there is less debate about the need for, and benefits of, EDC solutions as a powerful and necessary component in the clinical trial landscape. The discussion has moved beyond the question of whether EDC is useful, because these web-based systems are allowing investigators to log their findings directly into a centralised database, delivering accurate data in near real-time. These data may then be analysed for such purposes as reviewing the progress of clinical trials, supporting trial adaptation and reducing the costs of providing statisticians with study information. EDC also helps improve efficiencies – a benefit of great interest in drug development.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Simon Hawken has more than 20 years’ experience of selling solutions into the biopharmaceutical sector. He currently serves as Director of Business Development for eResearchTechnology, Inc – the well-established cardiac safety leader also providing eClinical solutions – and is based in the UK. He holds a BA degree in Economics and has worked for IMS Health, IBM Corporation, Xerox and BEA Systems Inc, among others.
spacer
Simon Hawken
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI South East Asia rescheduled for 2021

Amsterdam, 11 August 2020: CPhI South East Asia – organised by Informa Markets – has been rescheduled to May 18-20, 2021 to give the ASEAN pharma community more time to recover and to mitigate any global disruptions caused by COVID-19.
More info >>

White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement